Bollard Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-734
| Closed | -$53K | – | 366 |
|
|
2022
Q1 | $53K | Hold |
734
| – | – | ﹤0.01% | 335 |
|
|
2021
Q4 | $87K | Hold |
734
| – | – | ﹤0.01% | 306 |
|
|
2021
Q3 | $98K | Hold |
734
| – | – | ﹤0.01% | 285 |
|
|
2021
Q2 | $119K | Hold |
734
| – | – | ﹤0.01% | 263 |
|
|
2021
Q1 | $59K | Hold |
734
| – | – | ﹤0.01% | 333 |
|
|
2020
Q4 | $40K | Hold |
734
| – | – | ﹤0.01% | 354 |
|
|
2020
Q3 | $15K | Hold |
734
| – | – | ﹤0.01% | 396 |
|
|
2020
Q2 | $15K | Buy |
+734
| New | +$15K | ﹤0.01% | 419 |
|